PL2768527T3 - Wieloważna szczepionka przeciw CBV do zapobiegania lub leczenia cukrzycy typu 1 - Google Patents

Wieloważna szczepionka przeciw CBV do zapobiegania lub leczenia cukrzycy typu 1

Info

Publication number
PL2768527T3
PL2768527T3 PL12775490T PL12775490T PL2768527T3 PL 2768527 T3 PL2768527 T3 PL 2768527T3 PL 12775490 T PL12775490 T PL 12775490T PL 12775490 T PL12775490 T PL 12775490T PL 2768527 T3 PL2768527 T3 PL 2768527T3
Authority
PL
Poland
Prior art keywords
diabetes
preventing
treating type
cbv
vaccine
Prior art date
Application number
PL12775490T
Other languages
English (en)
Inventor
Heikki Hyöty
Mikael Knip
Olli Laitinen
Outi Tolonen
Minna Pulkki
Sami Oikarinen
Hanna-Riikka Honkanen
Valérie Lecouturier
Jeffrey Almond
Malin Flodström-Tullberg
Original Assignee
Vactech Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vactech Oy filed Critical Vactech Oy
Publication of PL2768527T3 publication Critical patent/PL2768527T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1009—Picornaviridae, e.g. hepatitis A virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
PL12775490T 2011-10-18 2012-10-18 Wieloważna szczepionka przeciw CBV do zapobiegania lub leczenia cukrzycy typu 1 PL2768527T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11306344.0A EP2583688A1 (en) 2011-10-18 2011-10-18 Multi-CBV vaccine for preventing or treating type 1 diabetes
EP12775490.1A EP2768527B1 (en) 2011-10-18 2012-10-18 Multi-cbv vaccine for preventing or treating type 1 diabetes
PCT/EP2012/070653 WO2013057191A1 (en) 2011-10-18 2012-10-18 Multi-cbv vaccine for preventing or treating type 1 diabetes

Publications (1)

Publication Number Publication Date
PL2768527T3 true PL2768527T3 (pl) 2017-12-29

Family

ID=47049165

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12775490T PL2768527T3 (pl) 2011-10-18 2012-10-18 Wieloważna szczepionka przeciw CBV do zapobiegania lub leczenia cukrzycy typu 1

Country Status (6)

Country Link
US (6) US20140255425A1 (pl)
EP (2) EP2583688A1 (pl)
DK (1) DK2768527T3 (pl)
ES (1) ES2643696T3 (pl)
PL (1) PL2768527T3 (pl)
WO (1) WO2013057191A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2583688A1 (en) * 2011-10-18 2013-04-24 Sanofi Pasteur Multi-CBV vaccine for preventing or treating type 1 diabetes
WO2023076856A1 (en) * 2021-10-25 2023-05-04 Provention Bio, Inc. Coxsackievirus b compositions and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60014077T2 (de) 1999-06-24 2005-10-20 Heikki Hyöty Vorbeugung von typ-1 diabetes und anderen nicht-polio enteroviren
US20100047273A1 (en) 2007-05-07 2010-02-25 Rino Rappuoli Coxsackie B virus and type 1 diabetes
DE102009034553A1 (de) * 2009-07-23 2011-01-27 Oerter, Detlef, Dr. Impfstoff zur Prävention von akuter lymphoblastischer Leukämie bei Kindern
EP2583688A1 (en) * 2011-10-18 2013-04-24 Sanofi Pasteur Multi-CBV vaccine for preventing or treating type 1 diabetes

Also Published As

Publication number Publication date
US20140255425A1 (en) 2014-09-11
WO2013057191A1 (en) 2013-04-25
US11633468B2 (en) 2023-04-25
DK2768527T3 (da) 2017-11-06
US10675344B2 (en) 2020-06-09
US10780157B2 (en) 2020-09-22
EP2583688A1 (en) 2013-04-24
EP2583688A9 (en) 2013-10-09
US10258685B2 (en) 2019-04-16
EP2768527B1 (en) 2017-08-09
EP2768527A1 (en) 2014-08-27
US20200000908A1 (en) 2020-01-02
US20170281748A1 (en) 2017-10-05
US20210220465A1 (en) 2021-07-22
US20210023196A1 (en) 2021-01-28
ES2643696T3 (es) 2017-11-23
US11911456B2 (en) 2024-02-27
US20190209675A1 (en) 2019-07-11

Similar Documents

Publication Publication Date Title
ZA201403795B (en) Formulations for the treatment of diabetes
HK1203826A1 (en) Methods and compositions for treating diabetes
AP2014007399A0 (en) Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament
EP2861263A4 (en) COMPOSITIONS AND METHODS FOR TREATING DIABETES
EP2774917A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES
HK1207579A1 (en) Composition for preventing or treating heart disease
HK1205464A1 (en) Preventing or treating periodontal disease
SG11201501289TA (en) Preparation for preventing or treating type i diabetes
PL2768527T3 (pl) Wieloważna szczepionka przeciw CBV do zapobiegania lub leczenia cukrzycy typu 1
IL238331A0 (en) A method for treating type I and type II diabetes
ZA201404542B (en) Fabric treatment composition
ZA201308117B (en) Avian-based treatment
EP2563353A4 (en) COMPOUNDS FOR ANTIFUNGAL TREATMENT
HK1196953A1 (zh) 用於治療糖尿病的製劑
GB201111247D0 (en) Treatment
GB201109119D0 (en) Treatment
GB201102269D0 (en) Treatment
GB201102268D0 (en) Treatment
GB201102273D0 (en) Treatment
GB201102288D0 (en) Treatment
GB201102284D0 (en) Treatment
GB201102277D0 (en) Treatment
GB201102265D0 (en) Treatment
GB201102282D0 (en) Treatment
GB201102263D0 (en) Treatment